Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The fda has approved a new drug with a unique mechanism of action for the treatment of chronic angina. Ranolazine reduces the frequency of chest pains by reducing the demand for oxygen but does not have significant effect on heart rate or blood pressure.

Ranolazine Extended-Release Tablets (RanexaTM)